McCutcheon RA, Harrison PJ, Howes OD, McGuire PK, Taylor DM, Pillinger T. Data-Driven Taxonomy for Antipsychotic Medication: A New Classification System. Biol Psychiatry. 2023 Apr 14:S0006-3223(23)01200-3. doi: 10.1016/j.biopsych.2023.04.004. Epub ahead of print. PMID: 37061079.
Harrison CH, Taquet M, Harrison PJ, Watkinson PJ, Rowland MJ. Sex and age effects on risk of non-traumatic subarachnoid hemorrhage: Retrospective cohort study of 124,234 cases using electronic health records. J Stroke Cerebrovasc Dis. 2023 May 23;32(8):107196. doi: 10.1016/j.jstrokecerebrovasdis.2023.107196. Epub ahead of print. PMID: 37230056.
Harrison PJ, Taquet M. Neuropsychiatric disorders following SARS-CoV-2 infection. Brain, 2023; awad008, https://doi.org/10.1093/brain/awad008.
Taquet M, Devinsky O, Cross JH, Harrison PJ, Sen A. Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis: A Retrospective Cohort Study. Neurology Feb 2023, 100 (8) e790-e799; DOI: 10.1212/WNL.0000000000201595.
Harrison PJ, Taquet M. Neuropsychiatric disorders following SARS-CoV-2 infection. Brain (AOL 2 Feb 2023).
Colbourne L, Harrison PJ. Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders. Molecular Psychiatry 27 3904-3912 (2022).
Harrison PJ, Husain SM, Lee H, De Los Angeles A, Colbourne L, Mould A, Hall NAL, Haerty W, Tunbridge EM. CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: advances from functional genomics and pharmacoepidemiology. Neuropharmacology 220 109262 (2022).
Harrison PJ, Mould A, Tunbridge EM. New drug targets in psychiatry: neurobiological considerations in the genomics era. Neuroscience and Biobehavioral Reviews 139 104763 (2022).
Foley EM, Griffiths SL, Murray A, Rogers J, Corsi-Zuelli F, Hickinbotham H, Warwick E, Wilson M, Kaser M, Murray GK, Deakin B, Jadon D, Suckling J, Barnes NM, Upthegrove R, Khandaker GM for the PIMS Collaboration. Protocol for the Psychosis Immune Mechanism Stratified Medicine (PIMS) trial: a randomised double-blind placebo-controlled trial of single-dose tocilizumab in patients with psychosis. BMJ Open 2023 Mar 24;13(3):e067944.
